Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

Frontiers in Immunology

Immunology

Yeny Acosta-Ampudia¹  Carolina Ramírez-Santana¹  Daniela Weiskopf²  Alba Grifoni²  José Mateus²  Alessandro Sette³  Beatriz Ariza⁴  Claudia Cecilia Cardozo-Romero⁴  Carlos Gómez-Restrepo⁵  Magda Cepeda⁵  Juliana Cuervo-Rojas⁵  Alexandria Dickson⁶  James D. Brien⁶  Andreu Gazquez⁶  Sandra Liliana Valderrama-Beltrán⁷  Julio César Castellanos⁸  John Mario González⁹  Norma Montoya^1,10  Luisa Murcia-Soriano^1,11  Manuel A. Franco^1,12  Federico Perdomo-Celis^1,12  Juana Ángel^1,12  Fabiola Martel^1,12 

[1] Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia;Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States;Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States;Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, United States;Clinical Laboratory Science Research Group, Clinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia;Department of Clinical Epidemiology and Biostatistics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia;Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States;Division of Infectious Diseases, Department of Internal Medicine. School of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio Infectious Diseases Research Group, Bogotá, Colombia;General Direction, Hospital Universitario San Ignacio, Bogotá, Colombia;Group of Basic Medical Sciences, School of Medicine, Universidad de Los Andes, Bogotá, Colombia;Head Clinical Laboratory Unit, Clínica del Occidente, Bogotá, Colombia;Hospital Universitario Mayor-Méderi, Universidad El Rosario, Bogotá, Colombia;Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia;

关键词: SARS-CoV-2;    variants;    natural infection;    vaccination;    antibody;    CD4+ T cell;    hybrid immunity;    breakthrough infections;   

DOI  :  10.3389/fimmu.2023.1274753

 received in 2023-08-08, accepted in 2023-08-09,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Martel, Cuervo-Rojas, Ángel, Ariza, González, Ramírez-Santana, Acosta-Ampudia, Murcia-Soriano, Montoya, Cardozo-Romero, Valderrama-Beltrán, Cepeda, Castellanos, Gómez-Restrepo, Perdomo-Celis, Gazquez, Dickson, Brien, Mateus, Grifoni, Sette, Weiskopf and Franco